https://www.pharmaceutical-technology.com/uncategorized/adocia-blood-sugar-technology/
Adocia has announced the initiation of a Phase I study of BioChaperone Pramlintide Insulin, that could better regulate glucose levels in diabetes patients.
blood sugar regulationbegintrialtechnology